Answers are grounded in this paper and cite their sources.
BiTP retains parent antibodies' binding affinity and bioactivity, with superior antitumor activity to parent antibodies in TNBC. Our data suggest that BiTP might be a promising agent for TNBC treatment.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: